Update
$Oncternal Therapeutics(ONCT.US$ Oncternal Therapeutics Enrolls Patients In Third Dosing Cohort Of Phase 1/2 Study Of ONCT-534![]()
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
